Focal Medical Technology

Company Overview

Snapshot

Founded in February 2022 by Adrian Paz, Focal Medical Technology operates with 1–10 employees. The company has raised $830,000 across four funding rounds from two investors, with Peregrine Ventures participating as a lead investor in multiple rounds. The company is actively developing its core technology in the medical device space.

Business overview

Focal Medical Technology is developing a minimally invasive, energy-based system designed for the precise mapping and focal ablation of prostate cancer. The company's core technology aims to provide advanced treatment options within the medical device sector, serving the healthcare industry, particularly providers focused on cancer treatments.

Company Intelligence Q&A

What is Focal Medical Technology's primary focus?

Focal Medical Technology is developing a minimally invasive, energy-based system for the mapping and focal ablation of prostate cancer.

When was Focal Medical Technology founded?

Focal Medical Technology was founded in February 2022.

Which investor has frequently participated in Focal Medical Technology's funding rounds?

Peregrine Ventures has participated in multiple funding rounds for Focal Medical Technology, including leading a round in August 2024 and providing follow-on funding in May and August 2025.

What was the company's first disclosed funding round?

In June 2022, Focal Medical Technology received $830,000 in funding from Peregrine Ventures and the Israel Innovation Authority.

Who is a founder of Focal Medical Technology?

Adrian Paz is a founder of Focal Medical Technology.